Investors

Copyright West LLC. Minimum 15 minutes delayed.

News Release

<< Back
Mar 5, 2012

OvaScience to Present at Cowen and Company’s 32nd Annual Health Care Conference

BOSTON, Mass., March 5, 2012 – OvaScience™, a fertility company focused on the discovery, development and commercialization of novel treatments for infertility, announced today that Michelle Dipp, M.D., Ph.D., chief executive officer of OvaScience, will present at the Cowen and Company 32nd Annual Health Care Conference on Wednesday, March 7, 2012 at 10:00 a.m. ET. The conference will be held March 5-7, 2012 at the Boston Marriott Copley Place.

About OvaScience

OvaScience is a privately-held fertility company focused on the discovery, development and commercialization of novel treatments for infertility. OvaScience was co-founded by Rich Aldrich, Michelle Dipp, M.D., Ph.D., and Christoph Westphal, M.D., Ph.D., of Longwood Fund, and Professors Jonathan Tilly, Ph.D., Massachusetts General Hospital and Harvard Medical School, and David Sinclair, Ph.D., Harvard Medical School.